Literature DB >> 16038754

Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.

Amyn Malik1, Paul Abraham, Nadia Malik.   

Abstract

Tenofovir disoproxil fumarate, a prodrug of tenofovir, is a potent nucleotide analogue reverse-transcriptase inhibitor with activity against human immunodeficiency virus (HIV). Although initially thought to be relatively safe with regards to nephrotoxic effects compared to its class drugs-adefovir and cidofovir, several cases of acute renal failure and proximal tubule dysfunction have been described in the last few months. We report another patient who developed Fanconi syndrome while on tenofovir. Her condition improved on discontinuation of the drug. We also review the literature of all patients who have developed Fanconi syndrome on tenofovir.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038754     DOI: 10.1016/j.jinf.2004.08.031

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  32 in total

1.  In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.

Authors:  Francesc Vidal; Joan Carles Domingo; Jordi Guallar; Maria Saumoy; Begoña Cordobilla; Rainel Sánchez de la Rosa; Marta Giralt; Maria Luisa Alvarez; Miguel López-Dupla; Ferran Torres; Francesc Villarroya; Tomas Cihlar; Pere Domingo
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 2.  Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Authors:  Atefeh Jafari; Hossein Khalili; Simin Dashti-Khavidaki
Journal:  Eur J Clin Pharmacol       Date:  2014-06-25       Impact factor: 2.953

Review 3.  Update on tenofovir toxicity in the kidney.

Authors:  Andrew M Hall
Journal:  Pediatr Nephrol       Date:  2012-08-10       Impact factor: 3.714

Review 4.  Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Authors:  Jérôme Tourret; Gilbert Deray; Corinne Isnard-Bagnis
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

5.  Development of osteomalacia in a post-liver transplant patient receiving adefovir dipivoxil.

Authors:  Masami Minemura; Yoshiharu Tokimitsu; Kazuto Tajiri; Yasuhiro Nakayama; Kengo Kawai; Hiroshi Kudo; Katsuharu Hirano; Yoshinari Atarashi; Yutaka Yata; Satoshi Yasumura; Terumi Takahara; Toshiro Sugiyama
Journal:  World J Hepatol       Date:  2010-12-27

6.  Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Authors:  Eric S Daar; Camlin Tierney; Margaret A Fischl; Paul E Sax; Katie Mollan; Chakra Budhathoki; Catherine Godfrey; Nasreen C Jahed; Laurie Myers; David Katzenstein; Awny Farajallah; James F Rooney; Keith A Pappa; William C Woodward; Kristine Patterson; Hector Bolivar; Constance A Benson; Ann C Collier
Journal:  Ann Intern Med       Date:  2011-02-14       Impact factor: 25.391

Review 7.  Pharmacists as providers of HIV pre-exposure prophylaxis.

Authors:  Christine Bruno; Parya Saberi
Journal:  Int J Clin Pharm       Date:  2012-10-17

8.  Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India.

Authors:  Sanjay Pujari; Ameet Dravid; Nikhil Gupte; Kedar Joshi; Vivek Bele
Journal:  Medscape J Med       Date:  2008-08-20

9.  Renal function with use of a tenofovir-containing initial antiretroviral regimen.

Authors:  Joel E Gallant; Richard D Moore
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

10.  Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India.

Authors:  Sanjay Pujari; Ameet Dravid; Nikhil Gupte; Kedar Joshix; Vivek Bele
Journal:  J Int AIDS Soc       Date:  2008-08-20       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.